Dr. Mayank Goyal, MD, FRCPC
Clinical Professor, Medical Director, Seaman Family MR Research Centre, Director, Imaging and Intervention, Calgary Stroke Program
Fellowship: Diagnostic and Interventional Neuroradiology, University of Toronto
Radiology Residency: All India Institute of Medical Sciences (AIIMS)
MD: All India Institute of Medical Sciences (AIIMS)
Dr. Mayank Goyal is a Clinical Professor in the Department of Radiology and Clinical Neurosciences at the University of Calgary. He is the Director of Imaging and Endovascular treatment at the Calgary Stroke Program. He is also the Medical Director of the Seaman Family MR Research Centre. Dr. Goyal has been a member of the Division of Neuroradiology at the Department of Radiology at the Cumming School of Medicine since 2007.
Dr. Goyal did his medical education and residency at the prestigious All India Institute of Medical Sciences, New Delhi, India. Subsequently he did a fellowship in Neuroradiology at the University of Toronto. Dr. Goyal’s passion and main research interest is acute stroke imaging, workflow and intervention. He has over 190 publications in peer-reviewed journals. He is one of the Principal Investigators in two global multi-centric trials in the field: ESCAPE and SWIFT PRIME (both published in NEJM). He was also the core-lab for the REVASCAT trial (published in NEJM). He is also the Co-PI of a CIHR funded study called PROVE IT. Dr. Goyal is world renowned for his ground-breaking work in efficiency and workflow in acute stroke intervention. He has extensively traveled across the world as a consequence of this expertise and has been one of the key components that helped the Calgary Stroke Program in becoming one of the best acute stroke programs in the world. He also came up with a new way of imaging in acute stroke called multiphase CT angiography. This technique subsequently became the basis for the PROVE IT study (which is study doing a head to head comparison between multiphase CTA and CT perfusion) and was implemented globally as part of the ESCAPE study. Initial results and feedback suggest that the technique is extremely useful and saves on average 20 minutes in acute stroke treatment (published in Radiology). With the success of ESCAPE and SWIFT PRIME, Dr. Goyal has been an integral part of changing stroke care across the world and helping thousands of patients have a good outcome from what is otherwise a devastating disease. He is also leading a meta-analysis (HERMES) consisting of the recent 5 positive trials published in NEJM. The first publication (Mayank as first author) was recently published in Lancet. The second paper analyzing the impact of time on outcome was recently published in JAMA (Mayank as co-first author). Dr. Goyal continues to push the boundaries of stroke research and is the Co-PI for a new trial (partially funded by CIHR) called ESCAPE-NA1 (testing the added usefulness of neuroprotection in addition to endovascular stroke therapy). Mayank enjoys teaching and successfully runs a yearly stroke course called 5T (where the 5Ts stand for: teamwork, transport, training, technique and technology).
Dr. Goyal is a Fellow of the Royal College of Physicians and Surgeons of Canada.
Dr. Mayank Goyal
Professor of Radiology and Clinical Neurosciences
Foothills Medical Centre
University of Calgary